Novel functional insights revealed by distinct protein-protein interactions of the residual SWI/SNF complex in SMARCA4-deficient small cell carcinoma of the ovary, hypercalcemic type
Authors:
- Elizabeth A. RaupachERElizabeth A. Raupach
- Krystine Garcia-MansfieldKGKrystine Garcia-Mansfield
- Ritin SharmaRSRitin Sharma
- Apurva M. HegdeAHApurva M. Hegde
- Victoria David-DirgoVDVictoria David-Dirgo
- Yemin WangYWYemin Wang
- Salvatore J. FacistaSFSalvatore J. Facista
- Rayvon MooreRMRayvon Moore
- Jessica D. LangJLJessica D. Lang
- Victoria L. ZismannVZVictoria L. Zismann
Preprint
Abstract
Chromatin remodeling plays a critical role in tumor suppression as demonstrated by 20% of human cancers bearing inactivating mutations in SWI/SNF chromatin remodeling complex members. Mutations in different SWI/SNF subunits drive a variety of adult and pediatric tumor types, including non-small cell lung cancers, rhabdoid tumors, medulloblastomas, and ovarian cancers. Small cell carcinoma of the ovary hypercalcemic type (SCCOHT) is an aggressive subtype of ovarian cancer occurring in young women. Nearly all (>98%) SCCOHTs have inactivating mutations in SMARCA4 , which encodes 1 of 2 mutually exclusive catalytic subunits of the SWI/SNF complex. Less than half of SCCOHT patients survive 5 years despite aggressive surgery and multimodal chemotherapy. Empirical support for effective SCCOHT treatments is scarce, in part because of the poor understanding of SCCOHT tumorigenesis. To gain insight into the functional consequences of SWI/SNF subunit loss, we defined SWI/SNF composition and its protein-protein interactions (PPIs) by immunoprecipitation and mass spectrometry (IP-MS) of SWI/SNF subunits in 3 SCCOHT cell lines. Comparing these results to a cell line containing a wild-type SWI/SNF complex, the interaction of most canonical core SWI/SNF subunits was observed in all SCCOHT cell lines at a lower abundance. The SCCOHT SWI/SNF also lacked ATPase module subunits and showed a drastic reduction in PBAF-specific subunit interactions. The wild-type and SCCOHT SWI/SNF subunits immunoprecipitated a shared set of 26 proteins, including core SWI/SNF subunits and RNA processing proteins. We observed 131 proteins exclusively interacting with the wild-type SWI/SNF complex including isoform-specific SWI/SNF subunits, members of the NuRD complex, and members of the MLL3/4 complex. We observed 60 PPIs exclusive to the SCCOHT residual SWI/SNF shared in at least 2 of the 3 SCCOHT cell lines, including many proteins involved in RNA processing. Differential interactions with the residual SWI/SNF complex in SCCOHT may further elucidate altered functional consequences of SMARCA4 mutations in these tumors as well as identify synthetic lethal targets that translate to other SWI/SNF-deficient tumors.Keywords
This publication has 72 references indexed in Scilit:
- A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbationNature Cell Biology, 2018
- Glioma tumor suppressor candidate region gene 1 (GLTSCR1) and its paralog GLTSCR1-like form SWI/SNF chromatin remodeling subcomplexesJournal of Biological Chemistry, 2018
- Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomicsScience Advances, 2015
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancyNature Genetics, 2013
- PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genesGenes & Development, 2005
- Selectivity of chromatin-remodelling cofactors for ligand-activated transcriptionNature, 2001
- Promoter targeting and chromatin remodeling by the SWI/SNF complexCurrent Opinion in Genetics & Development, 2000
- A multisubunit complex containing the SWI1/ADR6,SWI2/SNF2, SWI3, SNF5, and SNF6 gene products isolated fromyeast.Proceedings of the National Academy of Sciences, 1994
- Cell cycle control of the yeast HO gene: Cis- and Trans-acting regulatorsCell, 1987
- Five SWI genes are required for expression of the HO gene in yeastJournal of Molecular Biology, 1984